(Q42285184)

19 October 2017

title

Assessment of the in vivo biochemical efficacy of orally active leukotriene biosynthesis inhibitors (English)

1 reference

19 October 2017

P Tagari

1

1 reference

19 October 2017

C Brideau

2

1 reference

19 October 2017

C Chan

3

1 reference

19 October 2017

R Frenette

4

1 reference

19 October 2017

C Black

5

1 reference

19 October 2017

A Ford-Hutchinson

6

1 reference

19 October 2017

publication date

1 September 1993

1 reference

19 October 2017

1 reference

19 October 2017

volume

40

1 reference

19 October 2017

issue

1-2

1 reference

19 October 2017

page(s)

62-71

1 reference

Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01976753

Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01976753

Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01976753

Antigen-induced mediator release in primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01976753

"Helper" (CD4+) T cells and eosinophils in allergy and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01976753

Characteristics of formation and further metabolism of leukotrienes in the chopped human lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01976753

Leukotriene C4 elimination and metabolism in man

21 January 2018

1 reference

12 December 2020

Inactivation of leukotriene C4 in the airways and subsequent urinary leukotriene E4 excretion in normal and asthmatic subjects

1 reference

12 December 2020

Isolation and characterization of a cDNA clone encoding rat 5-lipoxygenase

1 reference

12 December 2020

Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist

1 reference

12 December 2020

Synthesis and metabolism of cysteinyl leukotrienes by the isolated pig kidney

1 reference

12 December 2020

Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis

1 reference

12 December 2020

Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses

1 reference

12 December 2020

Determination of plasma leukotrienes in antigen-induced bronchoconstrictive guinea pigs.

1 reference

12 December 2020

Reduced Allergen-Induced Nasal Congestion and Leukotriene Synthesis with an Orally Active 5-Lipoxygenase Inhibitor

1 reference

12 December 2020

Comparison of urinary leukotriene E4 and 16-carboxytetranordihydro leukotriene E4 excretion in allergic asthmatics after inhaled antigen

1 reference

12 December 2020

5-lipoxygenase inhibitory activity of zileuton

1 reference

12 December 2020

Exercise-Induced Urinary Excretion of Leukotriene E4 in Children with Atopic Asthma

1 reference

12 December 2020

Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic Subjects

1 reference

12 December 2020

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

1 reference

12 December 2020

Identification and isolation of a membrane protein necessary for leukotriene production

1 reference

12 December 2020

Urine leukotriene E4 levels are elevated in patients with active systemic lupus erythematosus

1 reference

12 December 2020

MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes

1 reference

12 December 2020

CGS 22745: a selective orally active inhibitor of 5-lipoxygenase

1 reference

12 December 2020

Entry rate and metabolism of leukotriene C4 into vascular compartment in healthy subjects

1 reference

12 December 2020

Prevention of endogenous leukotriene production during anaphylaxis in the guinea pig by an inhibitor of leukotriene biosynthesis (MK-886) but not by dexamethasone

1 reference

12 December 2020

Renal Clearance, Urinary Excretion of Endogenous Substances, and Urinary Diagnostic Indices in Healthy Neonatal Foals

1 reference

12 December 2020

The excretion of leukotriene E4 into urine following inhalation of leukotriene D4 by human individuals

1 reference

12 December 2020

Role of leukotrienes in an animal model of the adult respiratory distress syndrome

1 reference

12 December 2020

Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)- indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitor

1 reference

12 December 2020

The in vivo production of peptide leukotrienes after pulmonary anaphylaxis in the rat

1 reference

12 December 2020

Solubilization and partial purification of leukotriene C4 synthase from guinea-pig lung: a microsomal enzyme with high specificity towards 5,6-epoxide leukotriene A4

1 reference

12 December 2020

Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients

1 reference

12 December 2020

Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.

1 reference

12 December 2020

Application of reversed phase high performance liquid chromatography to the analysis of sulphidopeptide leukotrienes in pig bile

1 reference

12 December 2020

Urinary leukotriene E4 levels during early and late asthmatic responses†

1 reference

12 December 2020

Leukotriene generation and metabolism in dogs: inhibition of biosynthesis by MK-0591

1 reference

12 December 2020

Clinical and Biochemical Effects of an Oral Leukotriene Biosynthesis Inhibitor (MK886) in Psoriasis

1 reference

12 December 2020

Effect of inhaled piriprost (U-60, 257) a novel leukotriene inhibitor, on allergen and exercise induced bronchoconstriction in asthma

1 reference

12 December 2020

The effect of an oral leukotriene D4 antagonist L-649,923 on the response to inhaled antigen in asthma.

1 reference

12 December 2020

Metabolism of cysteinyl leukotrienes in monkey and man

1 reference

12 December 2020

Peptide leukotrienes: current status of research

1 reference

12 December 2020

Leukotriene E4 elimination and metabolism in normal human subjects

1 reference

12 December 2020

Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis

1 reference

12 December 2020

Inhibition of leukotriene biosynthesis in the rat peritoneal cavity

1 reference

12 December 2020

Measurement of urinary leukotrienes by reversed-phase liquid chromatography and radioimmunoassay

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01976753

1 reference

19 October 2017

1 reference